Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

H2-receptor antagonists: development and application.

S Feldman

    New England and Regional Allergy Proceedings
    |July 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    H2-receptor antagonists like ranitidine and cimetidine effectively treat peptic ulcers. Ranitidine offers greater potency and fewer side effects, guiding future therapeutic trends toward optimized acid control.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Immunogenicity of hepatitis B vaccine in healthy very low birth weight infants.

    The Journal of pediatrics·1997
    Same author

    Anaesthesia and the Research Assessment Exercise.

    Anaesthesia·1997
    Same author

    Depressed autoantibody synthesis in Trypanosoma cruzi-infected rats born to mothers undergoing this infection during pregnancy.

    Journal of reproductive immunology·1997
    Same author

    Neuromuscular block.

    Anaesthesia and intensive care·1997
    Same author

    The role of private-for-profit managed behavioral health in the public sector.

    Administration and policy in mental health·1997
    Same author

    Effect of glucocorticoids on the adrenocortical axis responses to electrical stimulation of the amygdala and the ventral noradrenergic bundle.

    Brain research·1997
    Same journal

    Official abstracts of papers o the XIII International Congress of Allergology and Clinical Immunology (ICACI). October 16-21, 1988, Montreux, Switzerland.

    New England and regional allergy proceedings·1988
    Same journal

    A new look at conifer allergy.

    New England and regional allergy proceedings·1988
    Same journal

    Eastern pine sensitivity in New England.

    New England and regional allergy proceedings·1988
    Same journal

    Mountain cedar pollinosis: can it occur in non-atopics?

    New England and regional allergy proceedings·1988
    Same journal

    The management of patients with sulfonamide allergy.

    New England and regional allergy proceedings·1988
    Same journal

    Exercise-induced anaphylaxis.

    New England and regional allergy proceedings·1988
    See all related articles

    Area of Science:

    • Gastroenterology
    • Pharmacology

    Background:

    • Peptic ulcer disease treatment has been revolutionized by H2-receptor antagonists.
    • Ranitidine and cimetidine are established treatments for healing and preventing ulcer relapse.

    Purpose of the Study:

    • To review the efficacy and safety of H2-receptor antagonists in peptic ulcer disease.
    • To compare ranitidine and cimetidine, highlighting their pharmacological differences.
    • To discuss current therapeutic trends and potential new applications for H2-receptor antagonists.

    Main Methods:

    • Review of existing literature on H2-receptor antagonists.
    • Comparative analysis of ranitidine and cimetidine based on chemical structure and clinical data.

    Main Results:

    Related Experiment Videos

    • Both ranitidine and cimetidine demonstrate safety and effectiveness in healing gastric and duodenal ulcers.
    • Ranitidine exhibits superior potency, longer duration of action, and a better side effect profile compared to cimetidine.
    • Therapeutic strategies are shifting towards less frequent dosing and nocturnal acid suppression.

    Conclusions:

    • H2-receptor antagonists are crucial in managing peptic ulcer disease.
    • Ranitidine presents advantages over cimetidine for patient treatment.
    • Future research may uncover additional therapeutic uses for this drug class.